Mehmet Kefeli, MD

Surgical Pathologist at @uniondokuzmayis Interested in GYN and endocrine pathology, trained at @MDAndersonNews and @UofT #GYNPath #Endopath 🔬📚🎾✈🌍📸

[Mehmet Kefeli, MD @MehmetKefeli]

📌Medullary #thyroid carcinomas may have different cytological/architectural patterns which potentially mimic other tms.
🔬Let's remember some faces of MTCs
#PathTwitter #pathology #ENTpathology #Entpath #pathologist #Endopath #endocrine @EndoPath @Pathologists @DrSultanClskn

[C. Christofer Juhlin @DrJuhlin]

In pheochromocytoma/paraganglioma, exploding genetic and molecular complexity means pathology is no longer just diagnosis - pathologists integrate histology, biomarkers & genetics to stratify risk and guide care. More essential than ever!

Read more:

https://t.co/QMBD89aVhs

[Springer Pathology @SpringerPath]

Biomarkers in Endocrine Pathology - submit today to be part of this @EndoPath collection

https://t.co/74LILubqjO

[Endocrine Pathology @EndoPath]

Study of FTC- vs PTC-derived anaplastic thyroid carcinomas confirms distinct mutational patterns and supports a progression model of ATC development, arguing against a de novo origin. Read it now!

https://t.co/UWSx3C9bkf

[Endocrine Pathology @EndoPath]

A must-read in Endocrine Pathology: This review proposes a new classification system for neuroendocrine tumors of the prostate, addressing key gaps in diagnosis, terminology, and management. Stay informed! Link below:

https://t.co/p0opAcz6yt

[Endocrine Pathology @EndoPath]

Big news! Endocrine Pathology now holds an Impact Factor of 14.7 - ranking us #2 out of 90 pathology journals. A huge thanks to our authors, reviewers, and readers. Submit your outstanding research and be part of the momentum!

[IJGC @IJGConline]

Improving pre-operative binary grading: relevance of #p53 and #PR expression in grade 2 endometrioid #endometrialcarcinoma

🔬 https://t.co/Xu58KCibA4

#IJGConline #Research #Prevention #Treatment #Diagnostic #GynCancer #GynOnc #WomenHealth #SoMe #SoMe4GynOnc

@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @thomasbartlMD @kfischermd @claritasantia @stephjeangill @MMontesinos_Alb @braunchristian1 @mattmarchettiMD @yates_elisemann @jhgelissen

[Endocrine Pathology @EndoPath]

Not all adrenal cancers are created equal!
Oncocytic ACC may look intense under the microscope - but it plays nicer than conventional ACC. Smaller tumors, fewer recurrences, better survival.

But beware: High Ki67 or advanced stage? Still trouble.

https://t.co/2LLeWRYIK1

[Endocrine Pathology @EndoPath]

Busting the BRAF hype in papillary thyroid cancer!

This study of 301 PTC patients found BRAF p.V600E is common - but not a crystal ball for recurrence. What did matter? Big nodal disease & being male.

@nicolecipriani

https://t.co/c5Buc1TqM5

[Springer Pathology @SpringerPath]

A study in Endocrine Pathology evaluates the use of pan-TRK immunohistochemistry (IHC) for detecting NTRK fusions in papillary thyroid carcinoma (PTC). The research highlights its correlation with histopathologic features and diagnostic utility.
https://t.co/eOndJF5iCE
@EndoPath

[Xiaoyin "Sara" Jiang, MD (She/Her) @Sara_Jiang]

Dr. Mete: beware of using CD56, CD57, PGP 9.5, NSE for confirming neuroendocrine differentiation! @EndoPath @TheUSCAP #USCAP2025

[irem onur @irem_onur_]

IS THIS A NICE FNA CASE OF THYROID FOLLICULAR NEOPLASM?
No. Prostatic adenocarcinoma metastatis to supraclavicular lymph node! PSAP (+) #FNA #thyroid #Diff_Quik #cytopath #cytology #cytopathology
@turkishcytopath

[Endocrine Pathology @EndoPath]

Biomarkers for anaplastic thyroid cancer are urgently needed, as these tumors often lose thyroid lineage markers. One promising option? SATB2! Here's why it could make a difference.

https://t.co/LM5EHEmTsk

[Endocrine Pathology @EndoPath]

Our journal features two ground-breaking papers in which a molecular link between well-differentiated NETs and high-grade NECs is proposed, arguing that a subset of well-differentiated cases may be at risk of progression!

https://t.co/rwLtXUt4mp

https://t.co/lYi3YlnXgq

[C. Christofer Juhlin @DrJuhlin]

Retroperitoneal tumor adjacent to the VCI in a 40 y/o male. Surgical excision is performed.

Tumor is composed of nests and solid areas embedded in a highly vascular stroma, the cytoplasm is granular and partly vacuolated. Rather monotonous nuclei.

Follow the thread for more!

[Endocrine Pathology @EndoPath]

Editor-in-Chief Dr Ozgur Mete and @SpringerPath are granting temporary free access to our special issues articles until 15th Oct to disseminate the knowledge! ENPA is a high-impact (IF 11.3) journal dedicated to endocrine pathology, endocrinology and endocrine oncology. 🔬🧬✨

[Endocrine Pathology @EndoPath]

Submit your research to Endocrine Pathology for more than just our impact factor. With an experienced, friendly editorial team, a broad readership, and a lightning-fast median handling time of just 3 days from submission to decision, you'll experience quality like never before!

[Endocrine Pathology @EndoPath]

The 2023 JIF for Endocrine Pathology is 11.3! ⭐️ We are now the 2nd highest ranked journal among pathology journals, and within the top ten lists among endocrinology&metabolism!

Fast turn-around time, superb production and friendly editorial handling! Submit your article today!

[Endocrine Pathology @EndoPath]

Hot off the press! Dr Mete and co-workers have analyzed a large cohort of appendiceal NETs, and identify three (not two!) subtypes of clinical importance. Now in open access in @EndocrinePath! Link below!

@TheEndoSociety @SpringerPath @UKEPSoc

https://t.co/G1yPOW6xMd

[International Society of Gynecologic Pathologists @ISGynP]

Announcing a free @ISGynP live virtual special webinar on 06/06 by Drs. Ganesan, Soslow & Hodgson. A panel discussion with the experts! Audience can submit questions in advance at [email protected]. Register now at https://t.co/uIM5YcRQ6l #gynpath #pathtwitter #pathology

[Turkish J Pathology @TurkJPath]

May issue is online !! Please check out our website for full texts !!